Ignelzi Troy A. 4
4 · Rapport Therapeutics, Inc. · Filed Feb 4, 2025
Insider Transaction Report
Form 4
Ignelzi Troy A.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-03+142,000→ 142,000 totalExercise: $16.60Exp: 2035-02-03→ Common Stock (142,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 1, 2025, subject to the Reporting Person's continued service on each such vesting date.